Vector BioMed Selected as Preferred Lentiviral Vector Manufacturing Partner for California Institute for Regenerative Medicine
- Wednesday, August 2, 2023, 7:02
- Finance
- Add a comment
GAITHERSBURG, Md., Aug. 2, 2023 /PRNewswire/ — Vector BioMed, a biomanufacturing company specializing in the manufacture of lentiviral vectors, today announced an agreement with the California Institute for Regenerative Medicine (CIRM) to be a lentiviral vector manufacturer within CIRM’s…
About the Author
adminasapcorp has written 39363 stories on this site.